{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:56:55Z","timestamp":1790834215309,"version":"4.1.0"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI140751"],"award-info":[{"award-number":["R01AI140751"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI089688"],"award-info":[{"award-number":["U19AI089688"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ijpddr.2021.04.002","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T13:42:22Z","timestamp":1619444542000},"page":"23-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["The molecular basis of antimalarial drug resistance in Plasmodium vivax"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5805-6574","authenticated-orcid":false,"given":"Lucas E.","family":"Buyon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Elsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj T.","family":"Duraisingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2021.04.002_bib1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/1475-2875-11-404","article-title":"Efficacy of artemether-lumefantrine as a treatment for uncomplicated Plasmodium vivax malaria in eastern Sudan","volume":"11","author":"Abdallah","year":"2012","journal-title":"Malar. J."},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002299","article-title":"Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: a randomized controlled trial","volume":"14","author":"Abreha","year":"2017","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/AAC.01200-06","article-title":"Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P","volume":"51","author":"Alam","year":"2007","journal-title":"falciparum. Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib4","first-page":"527","article-title":"[Therapeutic response of Plasmodium vivax to chloroquine in Bolivia]","volume":"32","author":"A\u00f1ez","year":"2012","journal-title":"Biomedica"},{"issue":"7481","key":"10.1016\/j.ijpddr.2021.04.002_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12936-015-0903-0","article-title":"Distribution of Plasmodium vivax pvdhfr and pvdhps alleles and their association with sulfadoxine\u2013pyrimethamine treatment outcomes in Indonesia","volume":"14","author":"Asih","year":"2015","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpddr.2011.08.001","article-title":"Phenotyping clinical resistance to chloroquine in Plasmodium vivax in northeastern Papua, Indonesia","volume":"1","author":"Asih","year":"2011","journal-title":"International Journal for Parasitology. Drugs and Drug Resistance"},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib8","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1038\/s41467-018-04965-4","article-title":"Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics","volume":"9","author":"Auburn","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ijpddr.2021.04.002_bib9","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/infdis\/jiz016","article-title":"Genomic analysis of plasmodium vivax in southern Ethiopia reveals selective pressures in multiple parasite mechanisms","volume":"220","author":"Auburn","year":"2019","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.002_bib10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/infdis\/jiw323","article-title":"Genomic analysis reveals a common breakpoint in amplifications of the plasmodium vivax multidrug resistance 1 locus in Thailand","volume":"214","author":"Auburn","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.ijpddr.2021.04.002_bib11","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1128\/AAC.00628-10","article-title":"Defining the role of mutations in plasmodium vivax dihydrofolate reductase-thymidylate synthase gene using an episomal plasmodium falciparum transfection system","volume":"54","author":"Auliff","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4269\/ajtmh.2006.75.617","article-title":"Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs","volume":"75","author":"Auliff","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib13","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/infdis\/171.6.1678","article-title":"Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine","volume":"171","author":"Baird","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4269\/ajtmh.1997.56.621","article-title":"Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels","volume":"56","author":"Baird","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4269\/ajtmh.1997.56.627","article-title":"In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia","volume":"56","author":"Baird","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1449","article-title":"Association of impaired cytochrome P450 2D6 activity genotype and phenotype with therapeutic efficacy of primaquine treatment for latent Plasmodium vivax malaria","volume":"1","author":"Baird","year":"2018","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.ijpddr.2021.04.002_bib17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1475-2875-10-282","article-title":"A new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes","volume":"10","author":"Barnadas","year":"2011","journal-title":"Malar. J."},{"issue":"12","key":"10.1016\/j.ijpddr.2021.04.002_bib18","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1128\/AAC.00578-08","article-title":"Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes","volume":"52","author":"Barnadas","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1475-2875-7-35","article-title":"Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine","volume":"7","author":"Barnadas","year":"2008","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib20","series-title":"Massachusetts Medical Society","article-title":"Primaquine failure and cytochrome P-450 2D6 in plasmodium vivax malaria [letter]","author":"Bennett","year":"2013"},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib21","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41467-018-04104-z","article-title":"Plasmepsin II\u2013III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum","volume":"9","author":"Bopp","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib22","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.1038\/s41598-018-28534-3","article-title":"Reuse of malaria rapid diagnostic tests for amplicon deep sequencing to estimate Plasmodium falciparum transmission intensity in western Uganda","volume":"8","author":"Boyce","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.002_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008506","article-title":"Population genomics identifies a distinct Plasmodium vivax population on the China-Myanmar border of Southeast Asia","volume":"14","author":"Brashear","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib24","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4269\/ajtmh.16-0566","article-title":"Longitudinal pooled deep sequencing of the plasmodium vivax K12 kelch gene in Cambodia reveals a lack of selection by artemisinin","volume":"95","author":"Brazeau","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.ijpddr.2021.04.002_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1086\/426830","article-title":"Identification of the plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity","volume":"191","author":"Brega","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib26","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3201\/eid1905.121852","article-title":"Genetic analysis of primaquine tolerance in a patient with relapsing vivax malaria","volume":"19","author":"Bright","year":"2013","journal-title":"Emerg. Infect. Dis."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002882","article-title":"A high resolution case study of a patient with recurrent plasmodium vivax infections shows that relapses were caused by meiotic siblings","volume":"8","author":"Bright","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib28","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1128\/AAC.05618-11","article-title":"The F423Y mutation in the pfmdr2 gene and mutations N51I, C59R, and S108N in the pfdhfr gene are independently associated with pyrimethamine resistance in plasmodium falciparum isolates","volume":"56","author":"Briolant","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib29","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/s41467-019-11239-0","article-title":"Antimalarial activity of primaquine operates via a two-step biochemical relay","volume":"10","author":"Camarda","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12936-017-2034-2","article-title":"Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia","volume":"16","author":"Chaorattanakawee","year":"2017","journal-title":"Malar. J."},{"issue":"7","key":"10.1016\/j.ijpddr.2021.04.002_bib31","doi-asserted-by":"crossref","first-page":"E232","DOI":"10.1111\/j.1469-0691.2012.03820.x","article-title":"Relapse of imported vivax malaria despite standard-dose primaquine therapy: an investigation with molecular genotyping analyses","volume":"18","author":"Chiang","year":"2012","journal-title":"Clin. Microbiol. Infect.: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib32","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1038\/s41467-019-11332-4","article-title":"Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages","volume":"10","author":"Chua","year":"2019","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ijpddr.2021.04.002_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002928","article-title":"The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: a systematic review and individual patient data meta-analysis","volume":"16","author":"Commons","year":"2019","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib34","first-page":"190","article-title":"In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010","volume":"48","author":"Congpuon","year":"2011","journal-title":"J. Vector Borne Dis."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12936-017-1806-z","article-title":"Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature","volume":"16","author":"Costa","year":"2017","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02257-16","article-title":"Selective whole-genome amplification is a robust method that enables scalable whole-genome sequencing of plasmodium vivax from unprocessed clinical samples","volume":"8","author":"Cowell","year":"2017","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13073-018-0563-0","article-title":"Exploration of Plasmodium vivax transmission dynamics and recurrent infections in the Peruvian Amazon using whole genome sequencing","volume":"10","author":"Cowell","year":"2018","journal-title":"Genome Med."},{"issue":"9","key":"10.1016\/j.ijpddr.2021.04.002_bib38","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1086\/606009","article-title":"Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa","volume":"200","author":"Dahlstr\u00f6m","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"50","key":"10.1016\/j.ijpddr.2021.04.002_bib39","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1073\/pnas.1812317115","article-title":"Mutations in Plasmodium falciparum actin-binding protein coronin confer reduced artemisinin susceptibility","volume":"115","author":"Demas","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/s12936-016-1592-z","article-title":"Genetic diversity of the Pvk12 gene in Plasmodium vivax from the China-Myanmar border area","volume":"15","author":"Deng","year":"2016","journal-title":"Malar. J."},{"issue":"46","key":"10.1016\/j.ijpddr.2021.04.002_bib41","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1003776107","article-title":"Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes","volume":"107","author":"Dharia","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(10)70079-7","article-title":"Artemisinin combination therapy for vivax malaria?","volume":"10","author":"Douglas","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"11","key":"10.1016\/j.ijpddr.2021.04.002_bib43","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.pt.2012.08.002","article-title":"PfCRT and its role in antimalarial drug resistance","volume":"28","author":"Ecker","year":"2012","journal-title":"Trends Parasitol."},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib44","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/S2666-5247(20)30094-X","article-title":"Molecular surveillance of antimalarial partner drug resistance in sub-Saharan Africa: a spatial-temporal evidence mapping study","volume":"1","author":"Ehrlich","year":"2020","journal-title":"The Lancet Microbe"},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib45","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12936-016-1595-9","article-title":"Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana","volume":"15","author":"Faway","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib46","first-page":"9","article-title":"Monitoring Plasmodium vivax resistance to antimalarials: persisting challenges and future directions","volume":"15","author":"Ferreira","year":"2021","journal-title":"Int. J. Parasitol.: Drugs and Drug Resistance"},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib47","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. Falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.002_bib48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1021\/acsinfecdis.5b00049","article-title":"Next-generation sequencing of plasmodium vivax patient samples shows evidence of direct evolution in drug-resistance genes","volume":"1","author":"Flannery","year":"2015","journal-title":"ACS Infect. Dis."},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1179\/000349802125001249","article-title":"The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia","volume":"96","author":"Fryauff","year":"2002","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib50","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4269\/ajtmh.1998.59.513","article-title":"Chloroquine-resistant plasmodium vivax in transmigration settlements of west Kalimantan, Indonesia","volume":"59","author":"Fryauff","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"11","key":"10.1016\/j.ijpddr.2021.04.002_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187376","article-title":"A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria","volume":"12","author":"Fukuda","year":"2017","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.ijpddr.2021.04.002_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00536-19","article-title":"Polymorphisms in plasmodium falciparum kelch 13 and P. Vivax kelch 12 genes in parasites collected from three South pacific countries prior to extensive exposure to artemisinin combination therapies","volume":"63","author":"Gresty","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.ijpddr.2021.04.002_bib53","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/cid\/ciw121","article-title":"Efficacy of artesunate-mefloquine for chloroquine-resistant plasmodium vivax malaria in Malaysia: an open-label, randomized, controlled trial","volume":"62","author":"Grigg","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54203-0","article-title":"Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs","volume":"9","author":"Gruenberg","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-3156.2007.01978.x","article-title":"Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar","volume":"13","author":"Guthmann","year":"2008","journal-title":"Trop. Med. Int. Health: TM & IH"},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib56","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","article-title":"Drug resistance in plasmodium","volume":"16","author":"Haldar","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.ijpddr.2021.04.002_bib57","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1128\/AAC.49.2.733-740.2005","article-title":"Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system","volume":"49","author":"Hastings","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib58","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1086\/381397","article-title":"Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine","volume":"189","author":"Hastings","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"20","key":"10.1016\/j.ijpddr.2021.04.002_bib59","doi-asserted-by":"crossref","first-page":"13137","DOI":"10.1073\/pnas.182295999","article-title":"Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax","volume":"99","author":"Hastings","year":"2002","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pt.2007.03.002","article-title":"Antifolates can have a role in the treatment of Plasmodium vivax","volume":"23","author":"Hawkins","year":"2007","journal-title":"Trends Parasitol."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.chom.2008.06.001","article-title":"Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of plasmodium falciparum invasion","volume":"4","author":"Hayton","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib62","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","article-title":"Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I","volume":"75","author":"Hill","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib63","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1475-2875-13-346","article-title":"Molecular surveillance of pvdhfr, pvdhps, and pvmdr-1 mutations in Plasmodium vivax isolates from Yunnan and Anhui provinces of China","volume":"13","author":"Huang","year":"2014","journal-title":"Malar. J."},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.002_bib64","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/ng.3588","article-title":"Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax","volume":"48","author":"Hupalo","year":"2016","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063433","article-title":"In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia","volume":"8","author":"Hwang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2021.04.002_bib66","first-page":"7","article-title":"Association of genetic mutations in plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates","volume":"11","author":"Imwong","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.ijpddr.2021.04.002_bib67","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1128\/AAC.49.10.4393-4395.2005","article-title":"Limited polymorphism in the dihydropteroate synthetase gene (dhps) of plasmodium vivax isolates from Thailand","volume":"49","author":"Imwong","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ijpddr.2021.04.002_bib68","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1128\/AAC.01459-07","article-title":"Gene amplification of the multidrug resistance 1 gene of plasmodium vivax isolates from Thailand, Laos, and Myanmar","volume":"52","author":"Imwong","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ijpddr.2021.04.002_bib69","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/512241","article-title":"Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites","volume":"195","author":"Imwong","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib70","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.molcel.2004.09.012","article-title":"Evidence for a central role for PfCRT in conferring plasmodium falciparum resistance to diverse antimalarial agents","volume":"15","author":"Johnson","year":"2004","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib71","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12936-018-2188-6","article-title":"Drug resistance genes: pvcrt-o and pvmdr-1 polymorphism in patients from malaria endemic South Western Coastal Region of India","volume":"17","author":"Joy","year":"2018","journal-title":"Malar. J."},{"issue":"24","key":"10.1016\/j.ijpddr.2021.04.002_bib72","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0804915","article-title":"A trial of combination antimalarial therapies in children from Papua New Guinea","volume":"359","author":"Karunajeewa","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijpddr.2021.04.002_bib73","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.actatropica.2005.10.003","article-title":"Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent","volume":"97","author":"Kaur","year":"2006","journal-title":"Acta Trop."},{"issue":"10","key":"10.1016\/j.ijpddr.2021.04.002_bib74","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3201\/eid2010.140411","article-title":"Effects of mefloquine use on plasmodium vivax multidrug resistance","volume":"20","author":"Khim","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib75","article-title":"Plasmodium vivax transcriptomes reveal stage-specific chloroquine response and differential regulation of male and female gametocytes","volume":"10","author":"Kim","year":"2019","journal-title":"Nat. Commun."},{"issue":"37","key":"10.1016\/j.ijpddr.2021.04.002_bib76","doi-asserted-by":"crossref","first-page":"13046","DOI":"10.1073\/pnas.0501747102","article-title":"Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance","volume":"102","author":"Kongsaeree","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib77","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1128\/AAC.48.6.2214-2222.2004","article-title":"Sulfadoxine resistance in plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site","volume":"48","author":"Korsinczky","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.ijpddr.2021.04.002_bib78","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/AAC.02727-13","article-title":"KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission","volume":"58","author":"Kuhen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib79","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01965-18","article-title":"Monitoring the efficacy of chloroquine-primaquine therapy for uncomplicated plasmodium vivax malaria in the main transmission hot spot of Brazil","volume":"63","author":"Ladeia-Andrade","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib80","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1128\/AAC.01572-09","article-title":"Plasmodium vivax susceptibility to ferroquine","volume":"54","author":"Leimanis","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ijpddr.2021.04.002_bib81","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/AAC.00169-08","article-title":"Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P","volume":"52","author":"Lek-Uthai","year":"2008","journal-title":"falciparum. Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008255","article-title":"Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes","volume":"14","author":"Li","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib83","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/ncomms2612","article-title":"Expansion of host cellular niche can drive adaptation of a zoonotic malaria parasite to humans","volume":"4","author":"Lim","year":"2013","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib84","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/infdis\/jiv142","article-title":"Using amplicon deep sequencing to detect genetic signatures of plasmodium vivax relapse","volume":"212","author":"Lin","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.002_bib85","first-page":"874","article-title":"Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. The Lancet","volume":"18","author":"Llanos-Cuentas","year":"2018","journal-title":"Infectious Diseases"},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib86","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1802537","article-title":"Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria","volume":"380","author":"Llanos-Cuentas","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ijpddr.2021.04.002_bib87","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood.2019000944","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"136","author":"Luzzatto","year":"2020","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.002_bib88","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1086\/501357","article-title":"Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia","volume":"42","author":"Maguire","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib89","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/AAC.01220-10","article-title":"Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P","volume":"55","author":"Marfurt","year":"2011","journal-title":"vivax. Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib90","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1086\/589882","article-title":"Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1","volume":"198","author":"Marfurt","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib91","first-page":"CD000256","article-title":"Artemisinin derivatives for treating uncomplicated malaria","volume":"2","author":"McIntosh","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7479","key":"10.1016\/j.ijpddr.2021.04.002_bib92","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature12782","article-title":"Targeting Plasmodium PI(4)K to eliminate malaria","volume":"504","author":"McNamara","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.002_bib93","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/gb-2011-12-8-r73","article-title":"Hybrid selection for sequencing pathogen genomes from clinical samples","volume":"12","author":"Melnikov","year":"2011","journal-title":"Genome Biol."},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.002_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105922","article-title":"Expression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon","volume":"9","author":"Melo","year":"2014","journal-title":"PloS One"},{"issue":"25","key":"10.1016\/j.ijpddr.2021.04.002_bib95","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A worldwide map of plasmodium falciparum K13-propeller polymorphisms","volume":"374","author":"M\u00e9nard","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00807","article-title":"Humanized mouse models for the study of human malaria parasite biology, pathogenesis, and immunity","volume":"9","author":"Minkah","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib97","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.3189","article-title":"Genetic architecture of artemisinin-resistant Plasmodium falciparum","volume":"47","author":"Miotto","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib98","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45829","article-title":"Rapid and iterative genome editing in the malaria parasite Plasmodium knowlesi provides new tools for P. vivax research","volume":"8","author":"Mohring","year":"2019","journal-title":"ELife"},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib99","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/mmi.12505","article-title":"Structural polymorphism in the promoter of pfmrp2 confers Plasmodium falciparum tolerance to quinoline drugs","volume":"91","author":"Mok","year":"2014","journal-title":"Mol. Microbiol."},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0020-7519(88)90138-5","article-title":"Erythrocytic schizogony and invasion of Plasmodium vivax in vitro","volume":"18","author":"Mons","year":"1988","journal-title":"Int. J. Parasitol."},{"issue":"2","key":"10.1016\/j.ijpddr.2021.04.002_bib101","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1073\/pnas.1216457110","article-title":"Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes","volume":"110","author":"Moon","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib102","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.3390\/molecules200610511","article-title":"Role and regulation of glutathione metabolism in plasmodium falciparum","volume":"20","author":"M\u00fcller","year":"2015","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib103","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1101\/gr.168286.113","article-title":"Single-cell genomics for dissection of complex malaria infections","volume":"24","author":"Nair","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib104","series-title":"Support Biomedical Research on Chimpanzees","year":"2015"},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","article-title":"The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis","volume":"42","author":"Nkhoma","year":"2009","journal-title":"Blood Cell Mol. Dis."},{"issue":"2","key":"10.1016\/j.ijpddr.2021.04.002_bib106","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.actatropica.2007.04.006","article-title":"Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi","volume":"102","author":"Nkhoma","year":"2007","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib107","first-page":"10","article-title":"Plasmodium falciparum multidrug resistance protein (MRP) gene expression under chloroquine and mefloquine challenge","volume":"2","author":"Nogueira","year":"2008","journal-title":"J. Cell Anim. Biol."},{"issue":"2","key":"10.1016\/j.ijpddr.2021.04.002_bib108","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/pathogens9020101","article-title":"Molecular detection of antimalarial drug resistance in plasmodium vivax from returned travellers to NSW, Australia during 2008\u20132018","volume":"9","author":"Noisang","year":"2020","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib109","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12936-017-1770-7","article-title":"Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009-2016)","volume":"16","author":"Nyunt","year":"2017","journal-title":"Malar. J."},{"issue":"16","key":"10.1016\/j.ijpddr.2021.04.002_bib110","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1073\/pnas.1501023112","article-title":"Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine","volume":"112","author":"Olafson","year":"2015","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"11","key":"10.1016\/j.ijpddr.2021.04.002_bib111","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/522154","article-title":"Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites","volume":"196","author":"Ord","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.002_bib112","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1128\/AAC.00004-09","article-title":"Analysis of single-nucleotide polymorphisms in the crt-o and mdr1 genes of Plasmodium vivax among chloroquine-resistant isolates from the Brazilian Amazon region","volume":"53","author":"Orjuela-S\u00e1nchez","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"50","key":"10.1016\/j.ijpddr.2021.04.002_bib113","doi-asserted-by":"crossref","first-page":"E8096","DOI":"10.1073\/pnas.1608828113","article-title":"Selective sweep suggests transcriptional regulation may underlie Plasmodium vivax resilience to malaria control measures in Cambodia","volume":"113","author":"Parobek","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib114","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/AAC.02207-15","article-title":"Expression of plasmodium vivax crt-o is related to parasite stage but not ex vivo chloroquine susceptibility","volume":"60","author":"Pava","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.002_bib115","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ng.3599","article-title":"Genomic analysis of local variation and recent evolution in Plasmodium vivax","volume":"48","author":"Pearson","year":"2016","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.ijpddr.2021.04.002_bib116","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/mmi.13035","article-title":"Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter","volume":"97","author":"Petersen","year":"2015","journal-title":"Mol. Microbiol."},{"issue":"296","key":"10.1016\/j.ijpddr.2021.04.002_bib117","doi-asserted-by":"crossref","first-page":"296ra111","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"7","author":"Phillips","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.ijpddr.2021.04.002_bib118","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/acsinfecdis.6b00144","article-title":"A triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor (DSM421) with improved drug-like properties for treatment and prevention of malaria","volume":"2","author":"Phillips","year":"2016","journal-title":"ACS Infect. Dis."},{"issue":"10","key":"10.1016\/j.ijpddr.2021.04.002_bib119","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/cid\/cir631","article-title":"Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial","volume":"53","author":"Phyo","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib120","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1128\/AAC.00241-08","article-title":"Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness","volume":"53","author":"Preechapornkul","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.ijpddr.2021.04.002_bib121","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/AAC.43.12.2943","article-title":"The pfmdr1 gene is associated with a multidrug-resistant phenotype in plasmodium falciparum from the western border of Thailand","volume":"43","author":"Price","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.ijpddr.2021.04.002_bib122","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1128\/AAC.00801-10","article-title":"In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax","volume":"54","author":"Price","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.ijpddr.2021.04.002_bib123","first-page":"982","article-title":"Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. The Lancet","volume":"14","author":"Price","year":"2014","journal-title":"Infectious Diseases"},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib124","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/infdis\/169.4.932","article-title":"Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria","volume":"169","author":"Pukrittayakamee","year":"1994","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1128\/AAC.38.3.511","article-title":"Antimalarial effects of rifampin in Plasmodium vivax malaria","volume":"38","author":"Pukrittayakamee","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib126","doi-asserted-by":"crossref","first-page":"14552","DOI":"10.1038\/srep14552","article-title":"Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite's food vacuole and alter drug sensitivities","volume":"5","author":"Pulcini","year":"2015","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ijpddr.2021.04.002_bib127","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1074\/jbc.M806944200","article-title":"Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione","volume":"284","author":"Raj","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008104","article-title":"Plasmodium vivax transcriptional profiling of low input cryopreserved isolates through the intraerythrocytic development cycle","volume":"14","author":"Rangel","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib129","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02519-17","article-title":"Enhanced ex vivo plasmodium vivax intraerythrocytic enrichment and maturation for rapid and sensitive parasite growth assays","volume":"62","author":"Rangel","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib130","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/JCM.00235-16","article-title":"A method for amplicon deep sequencing of drug resistance genes in plasmodium falciparum clinical isolates from India","volume":"54","author":"Rao","year":"2016","journal-title":"J. Clin. Microbiol."},{"issue":"9563","key":"10.1016\/j.ijpddr.2021.04.002_bib131","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(07)60160-3","article-title":"Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison","volume":"369","author":"Ratcliff","year":"2007","journal-title":"Lancet"},{"issue":"6772","key":"10.1016\/j.ijpddr.2021.04.002_bib132","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35002615","article-title":"Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum","volume":"403","author":"Reed","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib133","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12936-015-0791-3","article-title":"Monitoring PfMDR1 transport in plasmodium falciparum","volume":"14","author":"Reiling","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib134","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1475-2875-7-45","article-title":"Concentration and purification by magnetic separation of the erythrocytic stages of all human Plasmodium species","volume":"7","author":"Ribaut","year":"2008","journal-title":"Malar. J."},{"issue":"13","key":"10.1016\/j.ijpddr.2021.04.002_bib135","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1038\/sj.emboj.7601203","article-title":"Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum","volume":"25","author":"Rohrbach","year":"2006","journal-title":"EMBO J."},{"issue":"5996","key":"10.1016\/j.ijpddr.2021.04.002_bib136","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"Rottmann","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib137","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/AAC.01334-07","article-title":"Determinants of in vitro drug susceptibility testing of Plasmodium vivax","volume":"52","author":"Russell","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib138","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/AAC.47.1.170-173.2003","article-title":"Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic","volume":"47","author":"Russell","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"10.1016\/j.ijpddr.2021.04.002_bib139","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2011-04-348748","article-title":"A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax","volume":"118","author":"Russell","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000711","article-title":"Single-cell transcription analysis of Plasmodium vivax blood-stage parasites identifies stage- and species-specific profiles of expression","volume":"18","author":"S\u00e0","year":"2020","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-12256-9","article-title":"Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic cross","volume":"10","author":"S\u00e1","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib142","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.exppara.2004.12.005","article-title":"Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains","volume":"109","author":"S\u00e1","year":"2005","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib143","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2958.2008.06413.x","article-title":"Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum","volume":"70","author":"Sanchez","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib144","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2875-12-15","article-title":"Fitness components and natural selection: why are there different patterns on the emergence of drug resistance in Plasmodium falciparum and Plasmodium vivax?","volume":"12","author":"Schneider","year":"2013","journal-title":"Malar. J."},{"issue":"11","key":"10.1016\/j.ijpddr.2021.04.002_bib145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004196","article-title":"Multiple origins of mutations in the mdr1 gene\u2014a putative marker of chloroquine resistance in P. Vivax","volume":"9","author":"Schousboe","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"10","key":"10.1016\/j.ijpddr.2021.04.002_bib146","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/cit068","article-title":"Effectiveness of artemether\/lumefantrine for the treatment of uncomplicated Plasmodium vivax and P. falciparum malaria in young children in Papua New Guinea","volume":"56","author":"Senn","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib147","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1475-2875-7-94","article-title":"Plasmodium vivax trophozoites insensitive to chloroquine","volume":"7","author":"Sharrock","year":"2008","journal-title":"Malar. J."},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib148","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1365-2958.2005.04729.x","article-title":"Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum","volume":"57","author":"Sidhu","year":"2005","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib149","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12936-018-2411-5","article-title":"Chloroquine resistance is associated to multi-copy pvcrt-o gene in Plasmodium vivax malaria in the Brazilian Amazon","volume":"17","author":"Silva","year":"2018","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12936-018-2411-5","article-title":"Chloroquine resistance is associated to multi-copy pvcrt-o gene in Plasmodium vivax malaria in the Brazilian Amazon","volume":"17","author":"Silva","year":"2018","journal-title":"Malar. J."},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib151","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/trstmh\/traa002","article-title":"Global assessment of genetic paradigms of Pvmdr1 mutations in chloroquine-resistant Plasmodium vivax isolates","volume":"114","author":"Spotin","year":"2020","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib152","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1086\/650301","article-title":"In vivo parasitological measures of artemisinin susceptibility","volume":"201","author":"Stepniewska","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib153","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)80447-X","article-title":"Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa","volume":"91","author":"Su","year":"1997","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib154","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4269\/ajtmh.2003.68.416","article-title":"Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua","volume":"68","author":"Sumawinata","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"17","key":"10.1016\/j.ijpddr.2021.04.002_bib155","doi-asserted-by":"crossref","first-page":"E1759","DOI":"10.1073\/pnas.1322965111","article-title":"Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite's chloroquine resistance transporter","volume":"111","author":"Summers","year":"2014","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib156","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2875-9-52","article-title":"Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia","volume":"9","author":"Sutanto","year":"2010","journal-title":"Malar. J."},{"issue":"10","key":"10.1016\/j.ijpddr.2021.04.002_bib157","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/592451","article-title":"Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax","volume":"198","author":"Suwanarusk","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.ijpddr.2021.04.002_bib158","doi-asserted-by":"crossref","first-page":"e1089","DOI":"10.1371\/journal.pone.0001089","article-title":"Chloroquine resistant plasmodium vivax: in vitro characterisation and association with molecular polymorphisms","volume":"2","author":"Suwanarusk","year":"2007","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib159","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/infdis\/jiu491","article-title":"Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia","volume":"211","author":"Takala-Harrison","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.002_bib160","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02116-16","article-title":"Molecular epidemiology of plasmodium falciparum kelch13 mutations in Senegal determined by using targeted amplicon deep sequencing","volume":"61","author":"Talundzic","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10202","key":"10.1016\/j.ijpddr.2021.04.002_bib161","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(19)31285-1","article-title":"Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial","volume":"394","author":"Taylor","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"12","key":"10.1016\/j.ijpddr.2021.04.002_bib162","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1128\/AAC.46.12.3947-3953.2002","article-title":"Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations","volume":"46","author":"Tjitra","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib163","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1475-2875-11-214","article-title":"Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study","volume":"11","author":"Townell","year":"2012","journal-title":"Malar. J."},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.002_bib164","first-page":"415","article-title":"Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. The Lancet","volume":"15","author":"Tun","year":"2015","journal-title":"Infectious Diseases"},{"issue":"9","key":"10.1016\/j.ijpddr.2021.04.002_bib165","first-page":"952","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study. The Lancet","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Infectious Diseases"},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.002_bib166","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4269\/ajtmh.2012.12-0094","article-title":"Single-nucleotide polymorphism and copy number variation of the multidrug resistance-1 locus of plasmodium vivax: local and global patterns","volume":"87","author":"del C M Vargas-Rodr\u00edguez","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"7","key":"10.1016\/j.ijpddr.2021.04.002_bib167","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nmeth.3432","article-title":"Plasmodium falciparum genetic crosses in a humanized mouse model","volume":"12","author":"Vaughan","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ijpddr.2021.04.002_bib168","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.ijpddr.2021.04.002_bib169","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1128\/AAC.03337-14","article-title":"Complex polymorphisms in the plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response","volume":"58","author":"Veiga","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.ijpddr.2021.04.002_bib170","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.pt.2020.07.009","article-title":"Humanized mice and the rebirth of malaria genetic crosses","volume":"36","author":"Vendrely","year":"2020","journal-title":"Trends Parasitol."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib171","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007470","article-title":"Plasmodium knowlesi as a model system for characterising Plasmodium vivax drug resistance candidate genes","volume":"13","author":"Verzier","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"9","key":"10.1016\/j.ijpddr.2021.04.002_bib172","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1021\/acs.analchem.0c00547","article-title":"Dual-luciferase-based fast and sensitive detection of malaria hypnozoites for the discovery of antirelapse compounds","volume":"92","author":"Voorberg-van der Wel","year":"2020","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib173","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054888","article-title":"Transgenic fluorescent Plasmodium cynomolgi liver stages enable live imaging and purification of Malaria hypnozoite-forms","volume":"8","author":"Voorberg-van der Wel","year":"2013","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.002_bib174","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1073\/pnas.88.8.3382","article-title":"Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7","volume":"88","author":"Wellems","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1475-2875-10-297","article-title":"Determinants of relapse periodicity in Plasmodium vivax malaria","volume":"10","author":"White","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib176","series-title":"Technical Expert Group Meeting on Intermittent Preventive Treatment in Pregnancy (IPTp)","author":"WHO","year":"2007"},{"key":"10.1016\/j.ijpddr.2021.04.002_bib177","series-title":"WHO | Intermittent Preventive Treatment in Pregnancy (IPTp)","author":"WHO","year":"2019"},{"key":"10.1016\/j.ijpddr.2021.04.002_bib178","volume":"vol. 1","author":"WHO","year":"2019"},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib179","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev-micro-020518-115546","article-title":"Molecular mechanisms of drug resistance in plasmodium falciparum malaria","volume":"74","author":"Wicht","year":"2020","journal-title":"Annu. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.002_bib180","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4269\/ajtmh.1999.61.973","article-title":"Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand","volume":"61","author":"Wilairatana","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib181","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12936-015-0940-8","article-title":"Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry","volume":"14","author":"Wirjanata","year":"2015","journal-title":"Malar. J."},{"issue":"12","key":"10.1016\/j.ijpddr.2021.04.002_bib182","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1128\/AAC.03494-14","article-title":"Role of Pfmdr1 in in vitro plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin","volume":"58","author":"Wurtz","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib183","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12916-015-0456-7","article-title":"Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data","volume":"13","author":"WWARN","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.ijpddr.2021.04.002_bib184","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12916-015-0445-x","article-title":"Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data","volume":"13","author":"WWARN","year":"2015","journal-title":"BMC Med."},{"issue":"39","key":"10.1016\/j.ijpddr.2021.04.002_bib185","doi-asserted-by":"crossref","first-page":"14962","DOI":"10.1074\/jbc.RA118.004558","article-title":"Structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase\u2013dihydropteroate synthase from Plasmodium vivax sheds light on drug resistance","volume":"293","author":"Yogavel","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib186","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4269\/ajtmh.2011.09-0723","article-title":"Confirmed vivax resistance to chloroquine and effectiveness of artemether-lumefantrine for the treatment of vivax malaria in Ethiopia","volume":"84","author":"Yohannes","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.002_bib187","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12936-020-03354-x","article-title":"Molecular surveillance for drug resistance markers in Plasmodium vivax isolates from symptomatic and asymptomatic infections at the China\u2013Myanmar border","volume":"19","author":"Zhao","year":"2020","journal-title":"Malar. J."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320721000166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320721000166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:51:00Z","timestamp":1761922260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320721000166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":187,"alternative-id":["S2211320721000166"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2021.04.002","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The molecular basis of antimalarial drug resistance in Plasmodium vivax","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2021.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}